Position in BMEA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,042,014
+$203,290 QoQ
Shares Held
708,854
+29.3% QoQ
Ownership
0.978%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 61 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMEA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. BMEA ranks #317 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in BMEA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,042,014 | 708,854 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $838,724 | 548,186 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $697,993 | 562,898 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $902,685 | 446,874 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $492,879 | 273,822 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,333,279 | 625,953 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,344,089 | 604,147 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,074,937 | 601,479 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,687,345 | 597,188 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $7,379,783 | 493,631 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,974,275 | 480,322 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,236,596 | 453,241 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,444,997 | 430,296 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,582,957 | 212,285 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,368,079 | 162,287 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,590,540 | 162,632 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,084,741 | 90,546 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,117,680 | 250,601 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,697,065 | 227,794 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,852,022 | 154,722 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,251,914 | 144,261 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||